LEVOPROME Drug Patent Profile
✉ Email this page to a colleague
When do Levoprome patents expire, and what generic alternatives are available?
Levoprome is a drug marketed by Immunex and is included in one NDA.
The generic ingredient in LEVOPROME is levomepromazine. There are two drug master file entries for this compound. Additional details are available on the levomepromazine profile page.
Summary for LEVOPROME
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 38 |
Patent Applications: | 4,015 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LEVOPROME at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for LEVOPROME
US Patents and Regulatory Information for LEVOPROME
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunex | LEVOPROME | levomepromazine | INJECTABLE;INJECTION | 015865-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |